Renal Cancer - Results from #2020

Improving Renal Tumor Biopsy Prognostication With BAP1 Analyses. May 25, 2021

Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. May 25, 2021

Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data. May 24, 2021

Retroperitoneal Robot-Assisted Partial Nephrectomy (rRAPN): Surgical Technique and Review. May 24, 2021

Detection of von Hippel-Lindau gene mutation in circulating cell-free DNA for clear cell renal cell carcinoma. May 21, 2021

A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma. May 21, 2021

Autonomous pick-and-place using the dVRK. May 20, 2021

Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical In Vivo Models. May 20, 2021

Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma. May 19, 2021

Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 Study. May 19, 2021

Response to systemic therapy in fumarate hydratase-deficient renal cell carcinoma. May 18, 2021

Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma. May 18, 2021

TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study. May 17, 2021

Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[18F]FDG PET/CT. May 14, 2021

Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC). May 14, 2021

Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials. May 13, 2021

Prognostic Factors in De Novo Metastatic Renal Cell Carcinoma: A Report From the Latin American Renal Cancer Group. May 13, 2021

The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma. May 12, 2021

Adverse events of systemic immune-based combination therapies in the first-line treatment of patients with metastatic renal cell carcinoma: systematic review and network meta-analysis. May 12, 2021

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma. May 11, 2021

Page 102 of 456